Evidence Library
Filter by drug, type, year, and open access.
Showing 1–3 of 3 results
- The effect of switching antipsychotics to aripiprazole versus paliperidone on weight/cardiometabolic parameters: 18-month follow-up findings from the European Long-acting Antipsychotics in Schizophrenia Trial (EULAST) — European Neuropsychopharmacology (2026)• Drug: aripiprazolePMID
- Assessing the metabolic impact of aripiprazole versus risperidone in the treatment of schizophrenia: a randomized double-blind controlled clinical trial — BMC Psychiatry (2025)• Drug: aripiprazoleOpen accessPMID
- Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD) — Journal of Affective Disorders (2025)• Drug: aripiprazolePMID